
Early findings indicate that Sephin1 could lead to better clinical outcomes in MS patients as a safe, neuroprotective drug.

Early findings indicate that Sephin1 could lead to better clinical outcomes in MS patients as a safe, neuroprotective drug.

Investigators examined the interaction between the proteins TSP1 and C7 to look for a potential molecule to treat fibrosis in patients with butterfly syndrome.

New PANORAMA phase 3 trial results add to the anti-VEGF's profile for treatment of diabetic retinopathy.

The FDA has granted orphan drug designation to APX001 for the treatment of cryptococcosis.

Nicotine was detectable on children’s hands, even when caregivers reported not smoking around the child.

Universal screening for HCV infection is projected to be cost effective and provide greater benefit than the currently recommended birth cohort screening.

Only a few studies have examined over-diagnosis, which investigators note is common if the diagnosis is based on symptoms alone or on a pre-bronchodilator spirometry.

Since 2016, the health system has practiced a heart failure readmission reduction program that's improving patient quality of life.

What challenges—and opportunities—will present themselves in the varying fields of women's health in the following years?

Smokers assigned to e-cigarettes were more likely to remain abstinent than those offered nicotine-replacements like patches or gum. But questions about vaping safety remain.

The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

Investigators working on Glioblastoma Moon Shot program have made a key discovery on glioblastoma progression, identifying a key target to help stop it.

Investigators argued that reviews of healthcare interventions should include harmful side effects since they are essential to fully educate medical practice, health policies, and patients.

Investigators suggest the findings mean anticoagulants or antiplatelets could potentially treat migraine patients with aura.

Patients with influenza-like illness face a higher risk of stroke up to a year after infection.

Although novel antibiotics has improved in the pipeline over the past 6 years, inadequacy behind the momentum in the development of new infection-fighting agents still remains.

We asked women with a history of sexual trauma about their pregnancy and childbirth experiences and used their experiences and insight to inform practice recommendations.

A novel bioequivalent of dimethyl fumarate (Tecfidera) may soon be offering another treatment option for patients with multiple sclerosis.

The 2 patient groups have often been grouped into a singular 'Latino' designation in previous pediatric asthma studies. These findings show it's not an accurate representation of either group.

Investigators identified a correlation between infection with high-risk strains of HPV and increased risk of cardiovascular disease, especially among women with obesity or metabolic syndrome.

Cablivi (caplacizumab-yhdp) is the first approved treatment for adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Cablivi (caplacizumab-yhdp) is the first approved treatment for adults with acquired thrombotic thrombocytopenic purpura (aTTP).

Flu vaccination reduced influenza-related hospitalizations by 38% among patients with COPD.

Trazodone is a depression drug, but it blocks the integrated stress response, so it may be a good candidate for ALS.

A systematic review and meta-analysis of nearly 10,000 patients found systolic AOBP readings, under the right circumstances, should become the standard blood pressure test.

Patients administered either anti-VEGF therapy for nAMD tested similar for improved visual acuity over an observed 12-month treatment period.

The patient started treatment with resperidone at age 7 but wasn't diagnosed with tardive dyskinesia until age 17.

A cross-validated, stratified cohort found that certain epilepsy patient populations could be at a two-fold greater risk of AED-related psychiatric effects.

The updated software will begin being implemented this month for use with the Prometra Pump System.

Relebactam plus impenem/cilastatin and ceftolozane plus tazobactam are seeking indication for infection-based conditions later this year.